Financial Advocates Investment Management Amarin Corp Plcuk Transaction History

Financial Advocates Investment Management

$1.71 Billion
Q4 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.19 - $2.19 $14,280 - $26,280	-12,000 Reduced 47.06%	13,500 $20,000
Q4 2022 Feb 14, 2023	SELL	$1.07 - $1.34 $231,526 - $289,949	-216,380 Reduced 89.46%	25,500 $30,000
Q3 2022 Nov 14, 2022	SELL	$1.09 - $1.67 $201 - $308	-185 Reduced 0.08%	241,880 $264,000
Q2 2022 Aug 12, 2022	BUY	$1.13 - $3.69 $152 - $498	135 Added 0.06%	242,065 $360,000
Q1 2022 May 11, 2022	SELL	$2.85 - $3.73 $36,337 - $47,557	-12,750 Reduced 5.01%	241,930 $796,000
Q4 2021 Feb 14, 2022	BUY	$3.24 - $5.18 $347,490 - $555,555	107,250 Added 72.75%	254,680 $859,000
Q3 2021 Nov 04, 2021	SELL	$3.94 - $5.84 $2,167 - $3,212	-550 Reduced 0.37%	147,430 $752,000
Q2 2021 Aug 03, 2021	BUY	$4.26 - $6.5 $2,343 - $3,575	550 Added 0.37%	147,980 $655,000
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $85,930 - $112,943	-21,270 Reduced 12.61%	147,430 $721,000
Q3 2020 Nov 04, 2020	BUY	$3.64 - $7.76 $302,120 - $644,080	83,000 Added 96.85%	168,700 $710,000
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $119,500 - $206,500	25,000 Added 41.19%	85,700 $593,000
Q1 2020 Apr 29, 2020	BUY	$4.0 - $21.53 $38,800 - $208,841	9,700 Added 19.02%	60,700 $243,000
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $170,416 - $294,867	12,225 Added 31.53%	51,000 $1.09 Million
Q3 2019 Nov 13, 2019	BUY	$13.89 - $23.16 $135,774 - $226,389	9,775 Added 33.71%	38,775 $588,000
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $111,690 - $206,820	9,000 Added 45.0%	29,000 $394,000
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $24,500 - $162,700	10,000 Added 100.0%	20,000 $0
Q2 2018 Aug 09, 2018	BUY	$2.68 - $3.48 $26,800 - $34,800	10,000 New	10,000 $29,000

Others Institutions Holding AMRN

# of Institutions

181

Shares Held

68.6M

Call Options Held

192K

Put Options Held

78.1K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.

Account